Long-term persistence of immunity induced by OVA-coupled gas-filled microbubble vaccination partially protects mice against infection by OVA-expressing Listeria

Biomaterials

Volumn 57, Issue , 2015, Pages 153-160

  Bioley, Gilles ^a   Lassus, Anne ^b   Terrettaz, Jacques ^b   Tranquart, François ^b   Corthésy, Blaise ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Bracco Suisse SA   (Switzerland)

Author keywords

Antibody; Bacterial infection; Memory; Protection; T cells; Vaccine

Indexed keywords

ANTIBODIES; ANTIGENS; DATA STORAGE EQUIPMENT; DISEASES; IMMUNIZATION; LISTERIA; MAMMALS; PALMITIC ACID; SATURATED FATTY ACIDS; T-CELLS; VACCINES;

ANTIBODY RESPONSE; ANTIGEN DELIVERY SYSTEM; BACTERIAL INFECTIONS; DENDRITIC CELLS; MEMORY IMMUNE RESPONSE; PROTECTION; PROTECTIVE IMMUNITIES; SUBUNIT VACCINE;

IMMUNE SYSTEM;

BACTERIAL VACCINE; GAMMA INTERFERON; INTERLEUKIN 2; MACROGOL 2000; OVALBUMIN; PALMITIC ACID; T LYMPHOCYTE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL LOAD; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG FORMULATION; FEMALE; IMMUNE RESPONSE; INFECTION PREVENTION; LISTERIA MONOCYTOGENES; LISTERIOSIS; MICROBUBBLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; VACCINATION; ANIMAL; BAGG ALBINO MOUSE; GENE EXPRESSION; GENETIC RECOMBINATION; GENETICS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMAN; IMMUNITY; IMMUNOLOGY; LISTERIA;

BACTERIA (MICROORGANISMS); LISTERIA; MUS;

ANIMALS; BACTERIAL VACCINES; FEMALE; GENE EXPRESSION; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; IMMUNITY; INTERFERON-GAMMA; INTERLEUKIN-2; LISTERIA; MICE; MICE, INBRED BALB C; MICROBUBBLES; OVALBUMIN; RECOMBINATION, GENETIC; VACCINATION;

EID: 84928941033     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.04.008     Document Type: Article

References (36)

1. Koff W.C., Burton D.R., Johnson P.R., Walker B.D., King C.R., Nabel G.J., et al. Accelerating next-generation vaccine development for global disease prevention. Science 2013, 340:1232910.
2. Awate S., Babiuk L.A., Mutwiri G. Mechanisms of action of adjuvants. Front Immunol 2013, 4:114.
3. De Gregorio E., Caproni E., Ulmer J.B. Vaccine adjuvants: mode of action. Front Immunol 2013, 4:214.
4. Rosenthal J.A., Chen L., Baker J.L., Putnam D., DeLisa M.P. Pathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale. Curr Opin Biotechnol 2014, 28:51-58.
5. Jegerlehner A., Storni T., Lipowsky G., Schmid M., Pumpens P., Bachmann M.F. Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation. Eur J Immunol 2002, 32:3305-3314.
6. Kamath A.T., Mastelic B., Christensen D., Rochat A.F., Agger E.M., Pinschewer D.D., et al. Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responses. JImmunol 2012, 188:4828-4837.
7. Neeland M.R., Elhay M.J., Nathanielsz J., Meeusen E.N., de Veer M.J. Incorporation of CpG into a liposomal vaccine formulation increases the maturation of antigen-loaded dendritic cells and monocytes to improve local and systemic immunity. JImmunol 2014, 192:3666-3675.
8. Heit A., Schmitz F., Haas T., Busch D.H., Wagner H. Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity. Eur J Immunol 2007, 37:2063-2074.
9. Sahdev P., Ochyl L.J., Moon J.J. Biomaterials for nanoparticle vaccine delivery systems. Pharm Res 2014, 31:2563-2582.
10. Bioley G., Zehn D., Lassus A., Terrettaz J., Tranquart F., Corthesy B. The effect of vaccines based on ovalbumin coupled to gas-filled microbubbles for reducing infection by ovalbumin-expressing Listeria monocytogenes. Biomaterials 2013, 34:5423-5430.
11. Zhao Y.Z., Du L.N., Lu C.T., Jin Y.G., Ge S.P. Potential and problems in ultrasound-responsive drug delivery systems. Int J Nanomed 2013, 8:1621-1633.
12. Bioley G., Bussat P., Lassus A., Schneider M., Terrettaz J., Corthesy B. The phagocytosis of gas-filled microbubbles by human and murine antigen-presenting cells. Biomaterials 2012, 33:333-342.
13. Bioley G., Lassus A., Bussat P., Terrettaz J., Tranquart F., Corthesy B. Gas-filled microbubble-mediated delivery of antigen and the induction of immune responses. Biomaterials 2012, 33:5935-5946.
14. Carstens M.G., Camps M.G., Henriksen-Lacey M., Franken K., Ottenhoff T.H., Perrie Y., et al. Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines. Vaccine 2011, 29:4761-4770.
15. Abuchowski A., McCoy J.R., Palczuk N.C., van Es T., Davis F.F. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. JBiol Chem 1977, 252:3582-3586.
16. Ladel C.H., Flesch I.E., Arnoldi J., Kaufmann S.H. Studies with MHC-deficient knock-out mice reveal impact of both MHC I- and MHC II-dependent T cell responses on Listeria monocytogenes infection. JImmunol 1994, 153:3116-3122.
17. Messingham K.A., Badovinac V.P., Jabbari A., Harty J.T. Arole for IFN-gamma from antigen-specific CD8+ T cells in protective immunity to Listeria monocytogenes. JImmunol 2007, 179:2457-2466.
18. Cui W., Kaech S.M. Generation of effector CD8+ T cells and their conversion to memory T cells. Immunol Rev 2010, 236:151-166.
19. van Leeuwen E.M., Sprent J., Surh C.D. Generation and maintenance of memory CD4(+) T Cells. Curr Opin Immunol 2009, 21:167-172.
20. Nguyen M.T., Favelyukis S., Nguyen A.K., Reichart D., Scott P.A., Jenn A., et al. Asubpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. JBiol Chem 2007, 282:35279-35292.
21. Zhang X., Chentoufi A.A., Dasgupta G., Nesburn A.B., Wu M., Zhu X., et al. Agenital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge. Mucosal Immunol 2009, 2:129-143.
22. Snodgrass R.G., Huang S., Choi I.W., Rutledge J.C., Hwang D.H. Inflammasome-mediated secretion of IL-1beta in human monocytes through TLR2 activation; modulation by dietary fatty acids. JImmunol 2013, 191:4337-4347.
23. Jin Y., Wi H.J., Choi M.H., Hong S.T., Bae Y.M. Regulation of anti-inflammatory cytokines IL-10 and TGF-beta in mouse dendritic cells through treatment with Clonorchis sinensis crude antigen. Exp Mol Med 2014, 46:e74.
24. Dearman R.J., Cumberbatch M., Maxwell G., Basketter D.A., Kimber I. Toll-like receptor ligand activation of murine bone marrow-derived dendritic cells. Immunology 2009, 126:475-484.
25. Kaech S.M., Ahmed R. Immunology. CD8 T cells remember with a little help. Science 2003, 300:263-265.
26. Chandran S.S., Verhoeven D., Teijaro J.R., Fenton M.J., Farber D.L. TLR2 engagement on dendritic cells promotes high frequency effector and memory CD4 T cell responses. JImmunol 2009, 183:7832-7841.
27. Moyle P.M., Toth I. Self-adjuvanting lipopeptide vaccines. Curr Med Chem 2008, 15:506-516.
28. Redecke V., Hacker H., Datta S.K., Fermin A., Pitha P.M., Broide D.H., et al. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. JImmunol 2004, 172:2739-2743.
29. Deres K., Schild H., Wiesmuller K.H., Jung G., Rammensee H.G. Invivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 1989, 342:561-564.
30. Abou-Saleh R.H., Swain M., Evans S.D., Thomson N.H. Poly(ethylene glycol) lipid-shelled microbubbles: abundance, stability, and mechanical properties. Langmuir. ACS J Surf Colloids 2014, 30:5557-5563.
31. Croyle M.A., Chirmule N., Zhang Y., Wilson J.M. Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung. JVirol 2001, 75:4792-4801.
32. Papahadjopoulos D., Allen T.M., Gabizon A., Mayhew E., Matthay K., Huang S.K., et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci U. S. A. 1991, 88:11460-11464.
33. Perry J.L., Reuter K.G., Kai M.P., Herlihy K.P., Jones S.W., Luft J.C., et al. PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. Nano Lett 2012, 12:5304-5310.
34. Immordino M.L., Dosio F., Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomed 2006, 1:297-315.
35. Kreutz M., Tacken P.J., Figdor C.G. Targeting dendritic cells-why bother?. Blood 2013, 121:2836-2844.
36. Chen D., Zehrung D. Desirable attributes of vaccines for deployment in low-resource settings. JPharm Sci 2013, 102:29-33.